{
  "Cancer Histology Type (Ov)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20171128_CDC_B1B2_4,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        1710, 
        1724
      ]
    }
  ], 
  "Clinical History Heading (At)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20171128_CDC_B1B2_4,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        3392, 
        3415
      ]
    }
  ], 
  "Final Diagnosis Heading (At)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20171128_CDC_B1B2_4,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        1627, 
        1654
      ]
    }
  ], 
  "Macroscopic/Gross Description Heading (At)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20171128_CDC_B1B2_4,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        470, 
        499
      ]
    }
  ], 
  "Microscopic Heading (At)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20171128_CDC_B1B2_4,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        3315, 
        3350
      ]
    }
  ], 
  "Nature of Specimen Heading (At)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20171128_CDC_B1B2_4,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        1588, 
        1614
      ]
    }
  ], 
  "Neoplasm Behaviour (Ov)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20171128_CDC_B1B2_4,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        1691, 
        1699
      ]
    }
  ], 
  "Neoplasm Grade-Score Name (At)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Gemma,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        1726, 
        1733
      ]
    }
  ], 
  "Neoplasm Score Value (At)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Gemma,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        1744, 
        1745
      ]
    }
  ], 
  "Organ/Body Structure (At)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20171128_CDC_B1B2_4,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        1616, 
        1624
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20171128_CDC_B1B2_4,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        1700, 
        1709
      ]
    }
  ], 
  "Synoptic Report Heading (At)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": ",Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        1977, 
        1994
      ]
    }
  ], 
  "__text": "MSH|^~\\&|PathSys|Associated Pathologists, LLC d/b/a PathGroup^18D1004797^CLIA|eMARCPlus|KY Cancer Registry|20170919000156||ORU^R01^ORU_R01|201709190001560001|P|2.5.1|KY||||||||VOL_V_40_ORU_R01-CCR1^NAACCR_CP\nOBR|1||17-TJ-005087^PathSys^18D1004797^CLIA|11529-5^SURGICAL PATH REPORT^LN|||20170906000000|||||||20170907000000|&Prostate, Radical Resection|1689688871^^^^^^MD^^CMS^D^^^NPI||||||20170909000000|||F||||||C61^Malignant neoplasm of prostate^I10|&&&&&&&&CMS\n\n\n\n\n\n\n\nPath report.gross description\n\nReceived in formalin labeled with the patient's name and \"prostate\" is a single portion of tissue, grossly consistent with prostate, weighing 21 g and measuring 4.1 x 4.2 x 3.5 cm. The bilateral seminal vesicles and vasa deferentia are not discretely present. However, heavily cauterized tissue is present in the area of bilateral seminal vesicle and vasa deferentia. The specimen is inked as follows: Black = posterior, right = blue and left = green. The prostate apex is removed and submitted in cassettes A and B. The prostate base is then removed and submitted in cassettes C through E. The remaining portion of prostate is serially sectioned from apex to base. Cassettes F and G contain 1 slice, bisected. Cassettes H and I contain 1 slice, bisected. Cassettes J-M contain 1 slice, quadrisected. Cassettes N and O contain 1 slice, bisected. Cassettes P and Q contain 1 slice, bisected. Cassettes R-V contain 1 slice, quadrisected. Cassette W contains additional prostate tissue found within the container. The body of the prostate is submitted in cassettes F-V from apex to base.\n\n\nPath report.site of origin\n\nProstate\n\n\nPath report.final diagnosis\n\nProstate, radical prostatectomy:   Invasive prostatic adenocarcinoma, Gleason grade 3+4=7.   Carcinoma involves 15-20% of the prostate.   Carcinoma involves the right half of the prostate with focal     involvement in the left half of the prostate.   All margins free of involvement by carcinoma.   AJCC STAGE: pT2, pNX. CANCER CHECKLIST: PROSTATE GLAND: Radical Prostatectomy 3.000.001.1000043 SPECIMEN  Procedure: Radical prostatectomy Prostate Size  Prostate Weight (g): 21grams TUMOR  Histologic Type: Acinar adenocarcinoma Histologic Grade  Gleason Pattern: Gleason pattern  Primary Gleason Pattern: Pattern 3  Secondary Gleason Pattern: Pattern 4  Tertiary Gleason Pattern#: Not applicable  Total Gleason Score: 7  Grade Group: Grade group 2  Intraductal Carcinoma (IDC): Not identified Tumor Extent  Tumor Quantitation: Estimated percentage of prostate involved by tumor (specify %)  Estimated percentage of prostate involved by tumor (specify %): 15-20%  Extraprostatic Extension (EPE): Not identified  Urinary Bladder Neck Invasion: Not identified  Seminal Vesicle Invasion: Not identified Accessory Findings  Treatment Effect: No known presurgical therapy MARGINS  Margins: Uninvolved by invasive carcinoma LYMPH NODES  Regional Lymph Nodes: No lymph nodes submitted or found  Number of Lymph Nodes Examined: Specify number  Specify number: 0 PATHOLOGIC STAGE CLASSIFICATION (pTNM, AJCC 8th Edition)  TNM Descriptors: Not applicable  Primary Tumor (pT)#: pT2: Organ confined  Regional Lymph Nodes (pN): pNX: Regional lymph nodes cannot be assessed  Distant Metastasis (pM)#: Not applicable - pM cannot be determined from the submitted specimen(s)\n\n\nPath report.microscopic examination\n\nMicroscopic examination is performed.\n\n\nPath report.relevant Hx\n\nHistory - Prostate cancer\n\n\n"
}